tradingkey.logo

Xtant Medical Holdings Inc

XTNT

0.561USD

-0.012-2.04%
Horarios del mercado ETCotizaciones retrasadas 15 min
78.07MCap. mercado
PérdidaP/E TTM

Xtant Medical Holdings Inc

0.561

-0.012-2.04%
Más Datos de Xtant Medical Holdings Inc Compañía
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
Información de la empresa
Símbolo de cotizaciónXTNT
Nombre de la empresaXtant Medical Holdings Inc
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoMr. Sean E. Browne
Número de empleados217
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 30
Dirección664 Cruiser Lane
CiudadBELGRADE
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal59714
Teléfono14063880480
Sitio Webhttps://xtantmedical.com/
Símbolo de cotizaciónXTNT
Fecha de salida a bolsaJun 30, 2010
Director ejecutivoMr. Sean E. Browne
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.21M
-7.87%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
593.73K
-2.78%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
591.99K
-2.79%
Mr. Kevin D. Brandt
Mr. Kevin D. Brandt
Chief Commercial Officer
Chief Commercial Officer
337.88K
+49.10%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
234.31K
-4.39%
Ms. Lori Mitchell-Keller
Ms. Lori Mitchell-Keller
Independent Director
Independent Director
190.96K
-8.17%
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.21M
-7.87%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
593.73K
-2.78%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
591.99K
-2.79%
Mr. Kevin D. Brandt
Mr. Kevin D. Brandt
Chief Commercial Officer
Chief Commercial Officer
337.88K
+49.10%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
234.31K
-4.39%
Ms. Lori Mitchell-Keller
Ms. Lori Mitchell-Keller
Independent Director
Independent Director
190.96K
-8.17%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Orthobiologics
18.07M
54.93%
Spinal implant
11.21M
34.07%
License revenue
3.62M
11.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
30.12M
91.53%
Rest of World
2.79M
8.47%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Orthobiologics
18.07M
54.93%
Spinal implant
11.21M
34.07%
License revenue
3.62M
11.00%
Estadísticas de accionistas
Actualizado: vie., 18 de abr
Actualizado: vie., 18 de abr
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
49.09%
Lytton (Laurence W)
6.79%
Altium Capital Management LP
5.21%
Vizirgianakis (Stavros G)
4.46%
The Vanguard Group, Inc.
1.62%
Other
32.84%
Accionistas
Accionistas
Proporción
Nantahala Capital Management, LLC
49.09%
Lytton (Laurence W)
6.79%
Altium Capital Management LP
5.21%
Vizirgianakis (Stavros G)
4.46%
The Vanguard Group, Inc.
1.62%
Other
32.84%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
49.67%
Individual Investor
14.69%
Investment Advisor/Hedge Fund
5.66%
Investment Advisor
2.21%
Research Firm
0.02%
Other
27.74%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
66
100.67M
72.26%
-8.91M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
2023Q4
59
100.17M
77.23%
+1.05M
2023Q3
55
100.31M
77.56%
+9.94M
2023Q2
49
90.55M
83.28%
+1.27M
2023Q1
52
90.02M
82.83%
-239.03K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Nantahala Capital Management, LLC
68.39M
49.09%
+57.00M
+500.26%
Apr 10, 2025
Lytton (Laurence W)
9.46M
6.79%
+9.46M
--
Apr 15, 2025
Altium Capital Management LP
7.25M
5.21%
-162.41K
-2.19%
Mar 31, 2025
Vizirgianakis (Stavros G)
6.21M
4.46%
-530.88K
-7.87%
Feb 28, 2025
The Vanguard Group, Inc.
2.25M
1.62%
+100.60K
+4.68%
Mar 31, 2025
Browne (Sean E.)
1.51M
1.08%
+659.49K
+77.40%
Feb 28, 2025
Beeson (Jonn R.)
1.21M
0.87%
-16.98K
-1.38%
Feb 28, 2025
Renaissance Technologies LLC
711.21K
0.51%
-86.82K
-10.88%
Mar 31, 2025
Bakewell (John K)
593.73K
0.43%
-16.98K
-2.78%
Feb 28, 2025
McNamara (Robert E)
591.99K
0.42%
-16.98K
-2.79%
Feb 28, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI